Skip to main content
Equibles

Engineers Gate Manager LP

Position in MYGN — Myriad Genetics Inc

CIK 1620220 NEW YORK, NY
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$712,430
+$195,835 QoQ
Shares Held
124,769
+8.7% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#63
of 196 holders
Holding Since
Jun 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $81,977,054 across 22 Diagnostics & Research names. MYGN ranks #15 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 A
Agilent Technologies, Inc.
 126,957 $16,863,698
2 GH
Guardant Health, Inc.
 85,180 $12,779,555
3 NTRA
Natera, Inc.
 40,839 $11,085,746
4 TMO
Thermo Fisher Scientific Inc.
 18,701 $9,375,933
5 MTD
Mettler Toledo International Inc/
 6,175 $7,888,624
6 CRL
Charles River Laboratories International, Inc.
 29,267 $6,637,462
7 QGEN
Qiagen N.V.
 74,567 $2,915,569
8 IDXX
Idexx Laboratories Inc /De
 5,186 $2,730,117

All Filings in MYGN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $712,430 124,769
2026-03-31 $516,595 114,799
2025-12-31 $396,933 64,542
2025-09-30 $717,563 99,248
2025-06-30 $418,571 78,827
2025-03-31 $821,415 92,606
2024-12-31 $1,405,466 102,514
2024-09-30 $954,377 34,844
2024-06-30 $590,219 24,130
2023-12-31 $864,094 45,146
2023-09-30 $299,547 18,675
2023-06-30 $323,152 13,941
2022-09-30 $497,854 26,093
2022-06-30 $2,740,544 150,828
2022-03-31 $359,704 14,274
2021-09-30 $1,554,860 48,153
2020-09-30 $1,224,612 93,912
2020-06-30 $2,493,915 219,922